Literature DB >> 25220655

Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin.

B Visconti1, G Paolino1, S Carotti2, A L Pendolino2, S Morini2, A G Richetta1, S Calvieri1.   

Abstract

BACKGROUND: Cell junctions are crucial for the formation and maintenance of the paracellular barrier and for cell polarity in simple epithelia and endothelia. Altered localization and formation of tissue junction proteins in the epidermis have been described in plaque-type psoriasis. Vitamin D receptor (VDR) is a nuclear hormone involved in anti-proliferative and pro-differentiation pathways in keratinocytes. However, still to date, vitamin D/VDR signalling involved in tissue barrier related to psoriasis remains largely unknown.
OBJECTIVE: To study the expression of VDR and tight junctions (TJ) proteins (claudin 1, ZO-1 and occludin) in psoriatic skin, and to correlate the expression of VDR with that of the junctional proteins claudin- 1, occludin and ZO- 1.
METHODS: A total of 20 psoriatic tissue samples were included in the analysis. Immunohistochemical studies for VDR, claudin-1, occludin and ZO-1 were performed.
RESULTS: We observed a reduction of VDR, claudin-1 and ZO-1 expression in psoriatic skin if compared to normal skin, and the statistical analysis showed a significant correlation between a downgrading of VDR expression and that of claudin-1 (P < 0.005) and ZO-1(P < 0.005).
CONCLUSIONS: Our results suggest a new role of VDR in the maintenance of the homeostasis skin barrier. Although the exiguity of our cohort, VDR status appears to be associated with the expression level and functions of TJ proteins, suggesting multiple and different cellular functions of the VDR.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25220655     DOI: 10.1111/jdv.12736

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

1.  Association of rs1544410 and rs7975232 Polymorphisms and Serum Vitamin D Levels with Psoriasis Susceptibility and Severity: A Case-Control Study in Egyptian Patients.

Authors:  Amal Ahmed Mohamed; Eman Elhussain; Naglaa Fawzy; Yasser Sakr; Marwa Salah El-Dien; Abbas Mohammed Abbas; Maha S Hussein; Nourelhuda Nassar; Omnia Ezzat; Reham Yousry El-Amir; Sarah Ibrahim; Nermeen Ibrahim Bedair
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-07

2.  Disturbed expression of vitamin D and retinoic acid-related orphan receptors α and γ and of megalin in inflammatory skin diseases.

Authors:  Anna A Brożyna; Michał A Żmijewski; Kinga Linowiecka; Tae-Kang Kim; Radomir M Slominski; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2022-01-13       Impact factor: 4.511

3.  A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.

Authors:  Mary C Moran; Lisa A Beck; Christopher T Richardson
Journal:  J Invest Dermatol       Date:  2020-05       Impact factor: 8.551

Review 4.  Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist.

Authors:  Luigi Barrea; Maria Cristina Savanelli; Carolina Di Somma; Maddalena Napolitano; Matteo Megna; Annamaria Colao; Silvia Savastano
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

5.  Phosphodiesterase-4 Inhibition Reduces Cutaneous Inflammation and IL-1β Expression in a Psoriasiform Mouse Model but Does Not Inhibit Inflammasome Activation.

Authors:  Barbara Meier-Schiesser; Mark Mellett; Marigdalia K Ramirez-Fort; Julia-Tatjana Maul; Annika Klug; Nicola Winkelbeiner; Gabriele Fenini; Peter Schafer; Emmanuel Contassot; Lars E French
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

Review 6.  Vitamin D Receptor Influences Intestinal Barriers in Health and Disease.

Authors:  Jun Sun; Yong-Guo Zhang
Journal:  Cells       Date:  2022-03-27       Impact factor: 7.666

Review 7.  Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy.

Authors:  Anna A Brożyna; Radomir M Slominski; Bogusław Nedoszytko; Michal A Zmijewski; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 8.  Polymeric Gels and Their Application in the Treatment of Psoriasis Vulgaris: A Review.

Authors:  Agnieszka Kulawik-Pióro; Małgorzata Miastkowska
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

9.  MicroRNA-378a-3p is overexpressed in psoriasis and modulates cell cycle arrest in keratinocytes via targeting BMP2 gene.

Authors:  Wipasiri Soonthornchai; Pattarin Tangtanatakul; Kornvalee Meesilpavikkai; Virgil Dalm; Patipark Kueanjinda; Jongkonnee Wongpiyabovorn
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 10.  Psoriasis and inflammatory bowel disease: links and risks.

Authors:  Christoforos Vlachos; Georgios Gaitanis; Konstantinos H Katsanos; Dimitrios K Christodoulou; Epameinondas Tsianos; Ioannis D Bassukas
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.